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Introduction
The spindle assembly checkpoint (SAC) is activated during 
each mitosis to monitor the attachment of sister chromatids to 
the spindle (Musacchio and Hardwick, 2002). Upon biorienta-
tion of all sister chromatid pairs, the SAC is switched off, and 
anaphase ensues. SAC components such as products of the 
MAD (mitotic arrest defi  cient) and BUB (budding uninhibited 
by benzymidazole) genes are recruited to kinetochores in pro-
metaphase, where they monitor the attachment of microtubules 
and the tension that builds up between bipolarly attached sister 
chromatids (Cleveland et al., 2003).
Critical to the SAC is the interaction of Mad2 with Cdc20 
(Hwang et al., 1998; Kim et al., 1998). The latter is a positive 
regulator of the anaphase-promoting complex or cyclosome, 
whose function is required for progression into anaphase 
(  Peters, 2002). In mitosis, Mad2 is continuously recruited to ki-
netochores and is released from these structures in a form that 
binds Cdc20 and sequesters it in an inactive form (Howell et al., 
2000, 2004; Shah et al., 2004). When all chromosomes are 
aligned on the metaphase plate, Cdc20 is reactivated, and the 
consequent activation of the anaphase-promoting complex or 
cyclosome triggers anaphase.
Mad1 is required to recruit Mad2 at kinetochores and for 
effi  cient formation of the Mad2–Cdc20 complex. Two models 
have been proposed to explain the role of Mad1 in eliciting the 
formation of the Mad2–Cdc20 complex (for review see Hagan 
and Sorger, 2005; Hardwick, 2005; Nasmyth, 2005). The Mad2 
exchange model proposes that Mad1 recruits open Mad2 
(O-Mad2) at the kinetochore and changes its conformation from 
O-Mad2 to closed Mad2 (C-Mad2). C-Mad2 then dissociates 
from Mad1 and binds Cdc20. This model depicts Mad1 as a 
catalyst of the conversion of O-Mad2 into C-Mad2, which, in 
turn, is required for Mad2 to bind Cdc20 (Luo et al., 2004). 
However, the Mad2 exchange model is weakened by structural 
observations, indicating that Mad1 and Cdc20 bind the same 
pocket of Mad2. In the frame of the Mad2 exchange model, this 
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T
he spindle assembly checkpoint (SAC) coordinates 
mitotic progression with sister chromatid alignment. 
In mitosis, the checkpoint machinery accumulates at 
kinetochores, which are scaffolds devoted to microtubule 
capture. The checkpoint protein Mad2 (mitotic arrest de-
ﬁ  cient 2) adopts two conformations: open (O-Mad2) and 
closed (C-Mad2). C-Mad2 forms when Mad2 binds its 
checkpoint target Cdc20 or its kinetochore receptor Mad1. 
When unbound to these ligands, Mad2 folds as O-Mad2. 
In HeLa cells, an essential interaction between C- and 
O-Mad2 conformers allows Mad1-bound C-Mad2 to recruit 
cytosolic O-Mad2 to kinetochores. In this study, we show 
that the interaction of the O and C conformers of Mad2 
is conserved in Saccharomyces cerevisiae. MAD2 mutant 
alleles impaired in this interaction fail to restore the SAC in 
a mad2 deletion strain. The corresponding mutant proteins 
bind Mad1 normally, but their ability to bind Cdc20 is dra-
matically impaired in vivo. Our biochemical and genetic 
evidence shows that the interaction of O- and C-Mad2 is 
essential for the SAC and is conserved in evolution.
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implies that Mad1 and Cdc20 compete for Mad2 binding, which 
would rule out a role for Mad1 as a direct activator of Mad2 for 
Cdc20 binding (De Antoni et al., 2005a).
The Mad2 template model resolves this diffi  culty by in-
corporating a remarkable property of Mad2: the ability of its 
two conformers, O- and C-Mad2, to bind each other in a con-
formational dimer (Luo et al., 2004; De Antoni et al., 2005a,b). 
The model proposes that the kinetochore receptor of O-Mad2 
is a tight complex between Mad1 and C-Mad2 (the Mad1–
Mad2 core complex; Sironi et al., 2002; De Antoni et al., 
2005a). Mad1 provides this very sturdy complex with an 
N-terminal   kinetochore-targeting domain and a C-terminal 
Mad2-binding motif. The latter generates a stable form of 
  kinetochore-bound C-Mad2 that acts as the O-Mad2 receptor. 
In the Mad2 template model, the C-Mad2 pool bound to Mad1 
at the kinetochore and the O-Mad2 pool in the cytosol are dis-
tinct and nonexchanging. Thus, the model does not imply that 
Mad1 and Cdc20 compete for Mad2 binding, resolving the 
contradictions of the Mad2 exchange model (De Antoni et al., 
2005a; Nasmyth, 2005). Furthermore, the Mad2 template 
model provides a useful molecular framework to understand 
the existence of two distinct kinetochore pools of Mad2 re-
vealed by FRAP (Shah et al., 2004). Specifi  cally,  50% of 
kinetochore Mad2 exchanges rapidly at unattached kineto-
chores, whereas a remaining 50% of Mad2 is stably bound 
(Shah et al., 2004). The observation that Mad1 is also stable at 
unattached kinetochores (Howell et al., 2004; Shah et al., 
2004) prompted the suggestion that a stable Mad1–Mad2 
complex might be involved in the recruitment of a cycling cy-
tosolic fraction of Mad2 (Shah et al., 2004). When combined 
with the molecular information of the Mad2 template model, 
these experiments suggest that the kinetochore cycle of Mad2 
represents the rate of transformation of O-Mad2 into Cdc20-
bound C-Mad2.
An implication of the Mad2 template model is that the 
interaction of the O and C conformers of Mad2 facilitates the 
conversion of cytosolic O-Mad2 to Cdc20-bound C-Mad2. 
This might occur via mass action after concentrating O-Mad2 
and Cdc20 at kinetochores or possibly catalytically by facili-
tating the structural conversion of Mad2 from O- to C-Mad2. 
Although initial evidence has been provided indicating that the 
interaction of O- and C-Mad2 is important for the SAC in HeLa 
cells (De Antoni et al., 2005a,b), a more rigorous analysis is re-
quired. We studied the properties of the Saccharomyces cerevi-
siae’s homologue of Mad2 (ScMad2), asking whether we could 
identify the biochemical and genetic properties supporting the 
Mad2 template model in mammalian cells. Our new genetic and 
biochemical evidence is completely consistent with the Mad2 
template model.
Results
MAD2 mutants impaired in the open–closed 
interaction do not restore the SAC 
in a mad2∆ strain
Two mutants of HsMad2 (the point mutant Arg133-Ala and the 
double point mutant Arg133-Glu/Gln134-Ala, abbreviated as 
Mad2
RA and Mad2
RQEA, respectively) are impaired in the inter-
action between O- and C-Mad2 (Sironi et al., 2001; De Antoni 
et al., 2005a,b). The residues map to a solvent-exposed surface 
of Mad2, and their mutation does not signifi  cantly  affect 
Mad2’s structural stability (De Antoni et al., 2005a). The 
choice of using the Mad2
RQEA double mutant rather than the 
double alanine point mutant Mad2
RQAA arose because the re-
combinant form of the latter was largely insoluble, whereas 
good yields of Mad2
RQEA could be recovered from the soluble 
bacterial fraction (De Antoni et al., 2005a). Both Mad2
RA and 
Mad2
RQEA bind Mad1 and Cdc20 in vitro with identical affi  nity 
relative to wild-type Mad2 (Mad2
wt; Sironi et al., 2001, 2002; 
De Antoni et al., 2005a). Although the overexpression of 
Mad2
RA and Mad2
RQEA elicits a mitotic arrest (Sironi et al., 
2001; De Antoni et al., 2005a), near-physiological concentra-
tions of these mutant proteins were unable to support the SAC 
in HeLa cells concomitantly depleted of Mad2
wt by RNAi 
(De Antoni et al., 2005a).
To carry out more rigorous complementation experiments, 
we examined the effects of equivalent MAD2 mutations on the 
SAC in S. cerevisiae. Arg133 and Gln134 of HsMad2 are con-
served in evolution. The equivalent yeast residues are Arg126 
and Gln127 (Aravind and Koonin, 1998). We assayed the ability 
of ScMad2
wt, ScMad2-Arg126-Ala (ScMad2
RA), and ScMad2-
Gln127-Ala (ScMad2
QA) to restore the SAC defi  ciency caused 
by deleting MAD2 in S. cerevisiae. Cells arrested in G1 with α 
factor were released in the cell cycle in the presence of no-
codazole to activate the SAC. To assess SAC profi  ciency, we 
monitored (1) the ability to arrest in mitosis and to prevent re-
replication, (2) the lack of rebudding, and (3) the retention of 
sister chromatid cohesion. Wild-type cells completed DNA 
 replication  at   60 min after release from the G1 block in no-
codazole and arrested as budded cells with 2C DNA content 
without rebudding or separating the sister chromatids (Fig. 1, A 
and B), which is indicative of an active SAC. Conversely, 
mad2∆ cells were unable to arrest, lost sister chromatid cohe-
sion, rebudded, and re-replicated their DNA, which is indicative 
of a disrupted SAC.
To test the complementation potential of different MAD2 
alleles, we integrated wild-type and mutant MAD2 alleles at the 
LEU2 locus of the mad2∆ strain. Mad2
wt, Mad2
RA, and Mad2
QA 
were expressed at similar levels, and their expression was es-
sentially identical to that of endogenous Mad2 (see Fig. 7). The 
expression of Mad2
wt in the mad2∆ strain fully restored the 
SAC (Fig. 1, A and B). However, the expression of Mad2
RA and 
Mad2
QA failed to complement the lack of MAD2. Cells express-
ing these proteins underwent sister chromatid separation, re-
budding, and re-replication with timings that were very similar 
to those displayed by the bare mad2∆ strain.
The O and C conformers of ScMad2 
form a conformational dimer
These results demonstrate that the ScMad2 surface containing 
Arg126 and Gln127 is essential for the SAC, confi  rming our 
previous observations in HeLa cells (De Antoni et al., 2005a). 
The residues equivalent to Arg126 and Gln127 (Arg133 and 
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interaction of the O- and C-Mad2 conformers (De Antoni et al., 
2005a,b). It is possible that the inability of Mad2
RA and Mad2
QA 
to support the SAC in S. cerevisiae results from the impairment 
of an equivalent O-Mad2–C-Mad2 interaction. However, it is 
unknown whether ScMad2 is endowed with the same unusual 
biochemical features that characterize HsMad2 and that include 
the ability to adopt two stable conformations and the ability of 
the opposite conformers to form a complex. Thus, we set out 
to address the important question of whether two interacting 
  conformers of ScMad2 exist as shown previously for HsMad2 
(De Antoni et al., 2005a).
For this, we fi  rst tested the ability of purifi  ed recombinant 
ScMad2 to bind GST fusions of the Mad2-binding motifs of 
ScMad1 and ScCdc20 (GST-Mad1
563–590 and GST-Cdc20
184–210) 
in a solid phase binding assay (Fig. 2 A). Mad2
wt bound ef-
fectively to GST-Cdc20 and GST-Mad1 immobilized on 
  glutathione–Sepharose (GSH) beads (Fig. 2 A, lanes 6 and 10). 
As a result of the  40% sequence identity between HsMad2 
and ScMad2 and because the Mad2-binding motifs of Mad1 
and Cdc20 conform to the same consensus sequence in different 
species (Luo et al., 2002; Sironi et al., 2002), we assume that 
ScMad2 adopts a C-Mad2 conformation when bound to   ScMad1 
and ScCdc20 similar to that adopted by HsMad2 when bound to 
its human partners.
The deletion of 10 residues from the C terminus of 
 HsMad2  (HsMad2
∆C) affects the structural stability of the 
C-Mad2 conformer while leaving the stability of O-Mad2 un-
touched, creating a constitutively open form of Mad2 (Sironi 
et al., 2001, 2002; De Antoni et al., 2005a). Because the ability 
to reach the C-Mad2 conformation is critically required to bind 
Mad1 and Cdc20, Mad2
∆C is inapt to bind Mad1 or Cdc20 even 
if the residues within the deletion are not in direct contact with 
Mad1 or Cdc20 (Luo et al., 2000; Sironi et al., 2001, 2002; 
De Antoni et al., 2005a).
We created an equivalent mutant of ScMad2 (ScMad2
∆C) 
by deleting six residues from its C terminus (the C-terminal 
tail of ScMad2 is four residues shorter relative to HsMad2). 
Unlike ScMad2
wt, pure recombinant ScMad2
∆C was unable to 
bind GST-Mad1
563–590 or GST-Cdc20
184–210 (Fig. 2 A, lanes 7 
and 11). Essentially identical results were obtained in solution 
using isothermal titration calorimetry (Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200602109/DC1). Thus, 
ScMad2
∆C is a constitutively open form of Mad2 that is unable 
to bind Mad1 or Cdc20 and is similar in all of these respects 
to HsMad2
∆C (Luo et al., 2000; Sironi et al., 2001; De Antoni 
et al., 2005a).
We next tested whether the O- and C-Mad2 conformers 
of ScMad2 are capable of forming a complex like their human 
counterparts. First, we created C-Mad2 on solid phase by allow-
ing ScMad2
wt to bind GST-Mad1
563–590 and GST-Cdc20
184–210 as 
in the experiments shown in Fig. 2 A (lanes 6 and 10). This time, 
however, after washing out the excess of unbound Mad2
wt, we 
added Mad2
∆C (i.e., O-Mad2) to see whether it could be retained 
on solid phase via an interaction with the previously bound 
C-Mad2
wt. Indeed, ScMad2
∆C was found on solid phase in a 
complex with GST-Mad1
563–590–C-Mad2 and GST-Cdc20
184–210–
C-Mad2 (Fig. 2 A, lanes 8 and 12). This confi  rms the existence 
of an interaction of O- and C-Mad2 as described previously for 
HsMad2 (De Antoni et al., 2005a,b).
To test whether mutating Arg126 and Gln127 affects the in-
teraction between O- and C-Mad2, we repeated this experiment 
with ScMad2
RQEA after its expression in bacteria and purifi  cation 
to homogeneity. Like Mad2
wt, Mad2
RQEA bound effectively to 
GST-Mad1
563–590 and GST-Cdc20
184–210 (Fig. 2 B, lanes 6 and 10), 
indicating that this mutant can adopt the C-Mad2 conformation 
like Mad2
wt. Indeed, Mad2
wt and Mad2
RQEA bound Mad1 and 
Cdc20 synthetic peptides with essentially identical affi  nities 
in isothermal titration calorimetry   measurements (  Table S1). 
Figure 1.  The mad2
RA and mad2
QA point mutant alleles do not complement the deletion of the MAD2 gene in S. cerevisiae. Strains with the indicated geno-
types were grown to log phase, arrested in G1 by α factor, and released in fresh medium containing nocodazole. At the indicated times, cell samples were 
withdrawn for FACS analysis of DNA contents (A) and to score the percentage of budded and rebudded cells as well as the percentage of sister chromatid 
separation (B). wt, wild type.JCB • VOLUME 174 • NUMBER 1 • 2006  42
Next, we incubated Mad2
RQEA with GST-Mad1
563–590 or GST-
Cdc20
184–210 to create the closed conformer, washed away the ex-
cess of unbound Mad2
RQEA, and added Mad2
∆C (O-Mad2). This 
time, we failed to observe any retention of ScMad2
∆C on solid 
phase (Fig. 2 B, lanes 8 and 12). Given our previous analyses 
of the effects of mutating Arg133 and Gln134 in HsMad2 
(De Antoni et al., 2005a), the conservation of these residues in 
 ScMad2, and the identity of results with ScMad2 and HsMad2, we 
conclude that Arg126 and Gln127 map to the O-Mad2–  binding 
surface of C-Mad2 and that their concomitant mutation into 
  glutamate and alanine, respectively, prevents this interaction.
The interaction between O- and C-Mad2 was verifi  ed in 
solution using purifi  ed proteins (Fig. 2, C–G). Both ScMad2
∆C 
(O-Mad2) and the complexes of Mad2
wt or Mad2
RQEA with the 
high affi  nity Cdc20
195–211 synthetic peptide (C-Mad2) eluted as 
apparent monomers from a Superdex-200 size-exclusion chro-
matography (SEC) column (Fig. 2, C–E), indicating that both 
O- and C-Mad2 are monomeric (although the C-Mad2 species 
forms dimers with the Cdc20 peptide, this is only a 17-residue 
segment that does not signifi  cantly change the Stokes’ radius of 
Mad2). When combined stoichiometrically at 25°C for 60 min, 
ScMad2
∆C and the Mad2
wt–Cdc20
195–211 complex formed an O–C 
complex that eluted with a Stokes’ radius larger than that of 
the individual species and compatible with the molecular 
mass expected for an ScMad2 dimer ( 48 kD, as the molecu-
lar mass of the monomeric protein is  24 kD; Fig. 2 F). 
Figure 2.  The O and C conformers of ScMad2
wt form a complex that requires Arg126 and Gln127. (A) GST (lanes 1–4), GST-Mad1
563–590 (lanes 5–8), 
and GST-Cdc20
184–210 (lanes 9–12) were immobilized on GSH beads at  1.0 μM and incubated with  5 μM Mad2
wt or Mad2
∆C (lanes 13 and 14) for 
1 h. GSH beads were collected by centrifugation, washed, and bound proteins were analyzed by SDS-PAGE. For samples in lanes 8 and 12, beads were 
incubated with  5 μM Mad2
wt, washed, incubated with the same concentration of Mad2
∆C for an additional hour, and analyzed by SDS-PAGE. (B) The 
experiment was performed as in A but with Mad2
RQEA and Mad2
∆C. Although Mad2
RQEA binds GST-Mad1 and Cdc20 as well as Mad2
wt, it is unable to 
bind Mad2
∆C (lanes 8 and 12). (C) 50 μl of a 20-μM solution of Mad2
∆C was analyzed by SEC on a Superdex-200 PC 3.2/30 column and found to elute 
as a monomer. The content of 14 30-μl consecutive fractions eluting between 1.4 and 1.82 ml was analyzed by SDS-PAGE and was Coomassie stained. 
(D) To generate C-Mad2
wt, 200 μM Cdc20
195–211 synthetic peptide was incubated with 20 μM Mad2
wt for 1 h. The sample was analyzed by SEC as in C. 
(E) As in D but with Mad2
RQEA and the Cdc20
195–211 peptide. (F) C-Mad2
wt–Cdc20
195–211 was mixed with Mad2
∆C for 1 h before separation by SEC. 
  Dimerization of O and C conformers was revealed by a shift in elution volume relative to O- and C-Mad2. (G) The same experiment with C-Mad2
RQEA–
Cdc20
195–211 rather than with Mad2
wt shows that this double point mutant protein is unable to bind O-Mad2. AU, arbitrary unit.MAD2 ACTIVATION IN THE SPINDLE CHECKPOINT • NEZI ET AL. 43
Fractions corresponding to this peak contained apparently stoi-
chiometric amounts of each component. When ScMad2
∆C was 
combined with Mad2
RQEA–Cdc20
195–211 and the result of the in-
cubation was analyzed by SEC, no equivalent shift in the elu-
tion profi   le was observed (Fig. 2 F). Although ScMad2
∆C 
coeluted with Mad2
RQEA–Cdc20
195–211, the comparison of the 
peak of elution with those of the individual proteins displayed in 
Fig. 2 (C and E) clarifi  es that this was simply caused by the 
overlap of two distinct peaks with essentially identical elution 
volumes. These results confi  rm that the RQEA mutation affects 
the interaction of C- with O-Mad2.
We also investigated the state of the oligomerization of 
ScMad2
wt. Pure ScMad2
wt eluted from a Superdex-75 SEC col-
umn as a monomer (Fig. 3 A). To assess whether this monomer 
is O-Mad2, as expected for Mad2 in the absence of Mad1 or 
Cdc20, we examined the effects of adding increasing concen-
trations of the Cdc20
195–211 synthetic peptide on the SEC profi  le 
of ScMad2
wt. At a 4:1 Mad2/Cdc20
195–211 ratio, a dimeric spe-
cies roughly engaging 50% of total Mad2 appeared (Fig. 3 B). 
This can be easily explained if we assume that Cdc20
195–211 
transformed  1/4 of O-Mad2 in C-Mad2 and that this bound 
to an equimolar amount of O-Mad2, leaving half of the original 
O-Mad2 in the monomer peak. (As mentioned in the previous 
paragraph, the O–C dimer is actually a trimer if we consider 
Cdc20
195–211, but the latter does not contribute signifi  cantly to 
the elution profi  le of the O–C-Mad2 dimer.) Consistent with 
this hypothesis, at a 2:1 Mad2/Cdc20
195–211 ratio, most Mad2 
eluted as a dimer (Fig. 3 C). When the Mad2/Cdc20
195–211 
  ratio was decreased to cause the conversion of more O-Mad2 
to C-Mad2–Cdc20
195–211, the Mad2 dimer progressively disap-
peared, whereas a monomer peak corresponding to C-Mad2–
Cdc20
195–211 accumulated (Fig. 3, D and E). (Again, this is 
technically a dimer whose elution is not signifi  cantly infl  uenced 
by Cdc20
195–211). The elution volume of the C-Mad2 monomer 
was slightly but consistently retarded relative to that of the 
O-Mad2 monomer.
Altogether, the experiments in Figs. 2 and 3 strongly sug-
gest that the O and C conformers of ScMad2 form a dimeric 
complex like the one previously described for the equivalent 
conformers of HsMad2 (De Antoni et al., 2005a,b). The similar-
ity with HsMad2 extends to the fact that neither conformer 
forms dimers without the other conformer, contrary to the prop-
osition that C-Mad2 forms dimers (Luo et al., 2004). Further-
more, our data indicate that the interface containing Arg126 and 
Q127 of C-Mad2 is important for binding O-Mad2. In Fig. 4, 
we show that the converse is also true: namely, that a similar 
(but most likely not identical) interface in O-Mad2 is important 
for binding C-Mad2.
Figure 3.  Monomers and dimers of ScMad2
wt. Different Mad2 species (at 
a concentration of 20 μM) were analyzed using a Superdex-75 PC 3.2/30 
SEC column. For each panel, 14 30-μl fractions between 0.94 and 
1.36 ml were analyzed by SDS-PAGE. For each panel, the elution volumes 
of C-Mad2–O-Mad2 dimers (D) and the O-Mad2 monomer (M′) or C-Mad2 
monomer (M′′) are marked. In D and E, the black dotted lines mark the 
  elution volume of M′ (O-Mad2), which is shifted relative to M′′. (A) Pure 
ScMad2 eluted as a monomer. (B) Upon the addition of Cdc20
195–211 at 1/4 
of the Mad2 concentration,  50% of Mad2 is shifted into a dimer peak. 
(C) Cdc20
195–211 at 1/2 of the Mad2 concentration causes most Mad2 to 
shift into a dimer peak. (D) Upon the addition of superstoichiometric 
Cdc20, a C-Mad2 monomer accumulates. (E) The process of the creation 
of C-Mad2–Cdc20 is complete. AU, arbitrary unit.JCB • VOLUME 174 • NUMBER 1 • 2006  44
Binding of O-Mad2 to the Mad1–C-Mad2 
complex
Mad1 and Cdc20 bind the same Mad2 pocket and generate 
structurally similar C-Mad2 conformers. We have proposed that 
kinetochore recruitment of Mad2 requires a tight Mad1–Mad2 
complex at the kinetochore whose C-Mad2 component offers 
the critical binding surface for cytosolic O-Mad2 (Sironi et al., 
2002; De Antoni et al., 2005a). To test whether this is also the 
case for ScMad2, we created a recombinant ScMad1–ScMad2 
complex and purifi  ed it to homogeneity (Fig. 4 A). This com-
plex lacks the kinetochore-binding domain of Mad1 (located in 
the N-terminal half of Mad1) but contains coiled-coil segments 
that mediate the dimerization of Mad1 and two Mad2-binding 
domains, one per Mad1 chain, that are required for high affi  nity 
binding of Mad2. The resulting complex contains a very stable 
tetrameric core, as shown previously for an equivalent human 
complex (Sironi et al., 2001, 2002). Although we have not ana-
lyzed the stability of the ScMad1
529–750–ScMad2 complex in 
detail, we failed to observe any changes in the relative stoichi-
ometry of its components during purifi  cation, suggesting it is 
very stable.
To test the ability of purifi  ed O-Mad2 to bind C-Mad2 in 
the Mad1–Mad2 complex, we covalently attached the Alexa-
Fluor488 fl  uorophore to ScMad2
wt, ScMad2
∆C, or ScMad2
RQEA. 
We analyzed the resulting labeled proteins by SEC using a 
  Superdex-200 column (Fig. 4, B–D) after the elution of Alexa-
Fluor488-labeled Mad2 at 280 and 495 nm (Fig. 4, B–D; black 
and green traces, respectively). Excitation of the AlexaFluor 
fl  uorophore at 300 nm using a UV trans-illuminator provided a 
useful means of detecting the labeled protein in elution frac-
tions after SDS-PAGE separation. The same gels were also 
stained with Coomassie (Fig. 4, B–D; top and bottom gel 
  sections). This revealed that all three proteins eluted from the 
SEC column apparently as monomers.
We then mixed stoichiometric amounts of the fl  uorescent 
Mad2 species to the Mad1–Mad2 complex (at concentrations of 
 20 μM of monovalent Mad2 and 10 μM of divalent Mad1–
Mad2 core complex) and, after a 1-h incubation, we analyzed 
the products by SEC. AlexaFluor-labeled ScMad2
wt and 
ScMad2
∆C bound Mad1–Mad2 with high affi  nity, as evidenced 
by the essentially complete shift of the AlexaFluor fl  uorophore 
to fractions containing the Mad1–Mad2 core complex (Fig. 4, E 
and F). On the other hand, AlexaFluor-ScMad2
RQEA was unable 
to bind the Mad1–Mad2 core complex (Fig. 4 G). Addition of 
the Cdc20
195–211 synthetic peptide (at 200 μM) to “external” 
 AlexaFluor–O-Mad2
wt prebound to the Mad1–Mad2 core com-
plex resulted in dissociation of the AlexaFluor-labeled species 
in a low molecular weight complex, presumably in a complex 
with the Cdc20 peptide (Fig. 4 H). However, when the complex 
of O-Mad2
∆C with Mad1–Mad2 was tested with Cdc20
195–211, 
neither Mad2
∆C nor C-Mad2 that bound to Mad1 was released 
in a complex with Cdc20
195–211 (Fig. 4 I). This is consistent with 
the inability of Mad2
∆C to bind Cdc20 and shows that the 
Mad1–Mad2 complex is stable and is not disrupted by Cdc20. 
Consistently, C-Mad2 in the Mad1–Mad2 complex did not dis-
sociate from Mad1 if Cdc20
195–211 was added in the absence of 
external O-Mad2 (unpublished data).
Overall, these results are indistinguishable from those 
previously described for HsMad2 and its interaction with Mad1 
and Cdc20 (De Antoni et al., 2005a) and indicate that the 
O-Mad2 conformer of ScMad2 binds the C-Mad2 conformer in 
the Mad1–Mad2 complex. Because Mad2
∆C is unable to bind 
Mad1, whereas Mad2
RQEA is a normal Mad1 ligand, we con-
clude that Mad1 binding is not required for the binding reaction 
analyzed in Fig. 4. Rather, the interaction involves a surface 
predominantly or exclusively based on O- and C-Mad2. The ex-
periments reported in Fig. 4 show that O-Mad2
RQEA is unable to 
bind the wild-type C-Mad2 protein in the Mad1–Mad2   complex. 
Conversely, in Fig. 2, these mutations were shown to affect the 
binding to a functional O-Mad2 (ScMad2
∆C, whose defi  ciency 
consists uniquely in being unable to turn into C-Mad2). Thus, 
the surface containing Arg126 and Gln127 is involved in Mad2 
dimerization both on the O and C conformers.
Conformational analysis of O- and C-Mad2
Previous structural investigations demonstrated that human 
Mad2
∆C has the O-Mad2 conformation, that Mad2
wt and 
Mad2
R133A bound to Cdc20 or Mad1 are folded as C-Mad2, and 
that the two human conformers O- and C-Mad2 bind each other 
(Luo et al., 2000, 2002, 2004; Sironi et al., 2002; De Antoni 
et al., 2005a,b). For instance, human O-Mad2
∆C binds human 
Mad1–C-Mad2 (Fig. 5 A), which is a completely analogous re-
action to that involving yeast proteins in Fig. 4 F. So far, we 
  assumed that ScMad2 adopts O- and C-Mad2 conformations 
whose encounter results in their dimerization as for HsMad2. 
Although a direct structural investigation of the conformational 
states of ScMad2 goes beyond the purpose of this study, we 
wished to provide stronger evidence that ScMad2 adopts O- and 
C-Mad2 conformations like HsMad2. If ScMad2
∆C has the 
O-Mad2 conformation previously characterized for HsMad2
∆C, 
it might be expected to bind human C-Mad2. To test this, we 
mixed stoichiometric amounts of human Mad1–C-Mad2 com-
plex (Sironi et al., 2002) with AlexaFluor-ScMad2
∆C and ana-
lyzed the resulting species by SEC on a Superdex-200 column 
(Fig. 5 B). Confi  rming our expectation that ScMad2
∆C has the 
same O-Mad2 conformation that was previously demonstrated 
for HsMad2
∆C (Luo et al., 2000), AlexaFluor-ScMad2
∆C co-
eluted with the human Mad1–C-Mad2 complex. Binding was 
specifi  c because AlexaFluor-ScMad2
wt that preincubated with 
the ScCdc20
195–211 synthetic peptide to create C-Mad2 failed to 
bind the human Mad1–Mad2 complex (Fig. 5 C).
Conversely, if Mad1-bound ScMad2 has the same C-Mad2 
conformation previously observed in the structure of the human 
Mad1–C-Mad2 complex (Sironi et al., 2002), it might be 
  expected to bind human Mad2
∆C, which has been shown to fold 
as O-Mad2 (Luo et al., 2000). Indeed, AlexaFluor-HsMad2
∆C 
bound tightly to the S. cerevisiae Mad1–Mad2 complex (Fig. 
5  D), strongly suggesting that the conformation of ScMad2 
bound to ScMad1 is C-Mad2. Preincubation of HsMad2
wt with 
a synthetic peptide encompassing the Mad2-binding site of 
HsCdc20 (Cdc20
111–138) to create human C- Mad2 prevented its 
binding to the S. cerevisiae Mad1–Mad2 complex (Fig. 5 E). 
These experiments indicate that the interface mediating the in-
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Figure 4.  O-Mad2 binds the Mad1–Mad2 core complex. (A) Mad1–Mad2 forms a stable tetrameric assembly, the Mad1–Mad2 core complex (Sironi 
et al., 2002). A recombinant yeast complex containing the C-terminal region of Mad1 (residues 529–750 lacking the N-terminal kinetochore-binding do-
main of Mad1) was coexpressed in bacteria with Mad2
wt, and the resulting complex was puriﬁ  ed to homogeneity (see Materials and methods). 50 μl 
Mad1–Mad2 complex (10 μM) was analyzed by SEC on a Superdex-200 PC 3.2/30 column. Fractions between 1.15 and 1.85 ml were analyzed by 
SDS-PAGE. (B) SEC proﬁ  le of Mad2
wt covalently labeled with AlexaFluor488. The content of the elution fractions was analyzed after SDS-PAGE on a UV 
trans-illuminator (top) and by Coomassie staining (bottom). (C and D) AlexaFluor488-Mad2
∆C (C) and AlexaFluor488-Mad2
RQEA (D) was analyzed as in B. 
(E) Mad2
wt (O-Mad2) was incubated stoichiometrically with Mad1
529–750–Mad2
wt, and the resulting sample was analyzed by SEC. Most of the Alexa-
Fluor488 signal associated with Mad2
wt was incorporated in a high molecular weight complex, indicating binding to Mad1–Mad2. (F) The same experi-
ment was repeated using AlexaFluor488-Mad2
∆C. Also in this case, the AlexaFluor signal was shifted to a high molecular weight complex with 
Mad1–Mad2. (G) AlexaFluor488-Mad2
RQEA fails to bind Mad1–Mad2, indicating that Arg126 and Gln127 are part of the binding interface. (H) Mad2
wt 
was incubated stoichiometrically with Mad1
529–750–Mad2
wt in the presence of Cdc20
195–211. The AlexaFluor488 signal associated with Mad2
wt is released 
from the Mad1–Mad2 complex. (I) As in H but with AlexaFluor488-Mad2
∆C, which does not bind Cdc20 and is not released from Mad1–Mad2. 
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(as already exemplifi  ed by the conservation of R126 and Q127), 
underscoring the biological importance of Mad2 dimerization 
in checkpoint function.
Mad2
∆C abrogates the checkpoint
The results of our biochemical characterization of ScMad2 are 
consistent with the Mad2 template model (De Antoni et al., 
2005a,b). The latter depicts C-Mad2 stably bound to Mad1 
(rather than Mad1 itself) as a trigger that is required for Mad2 
to bind Cdc20 in living cells. In this view, the absolute re-
quirements for Mad1 in activating Mad2 for Cdc20 binding 
are   limited to its function in localizing a pool of C-Mad2 to 
the kinetochore. This form of C-Mad2 recruits O-Mad2 from 
the cytosol to assist in its transformation into C-Mad2 bound 
to Cdc20. To provide more evidence in favor of this model, 
we asked whether interfering with the O–C-Mad2 interaction 
weakens the SAC response. Because O-Mad2
∆C binds C-Mad2 
but is unable to be passed onto Cdc20 (Fig. 4), this mutant is 
expected to compete with the binding of O-Mad2
wt to C-Mad2, 
and we asked whether its expression perturbed the SAC re-
sponse in S. cerevisiae. First, we determined that ScMad2
∆C 
expressed from the endogenous MAD2 promoter is unable to 
sustain the checkpoint in a mad2∆ strain (Fig. S1, A and B; avail-
able at http://www.jcb.org/cgi/content/full/jcb.200602109/DC1), 
which is consistent with a previous study (Chen et al., 1999) 
and with our own observation that ScMad2
∆C is unable to bind 
Mad1 or Cdc20.
To test our hypothesis, we expressed ScMad2
∆C from the 
GAL1 promoter and tested checkpoint function after the release 
of wild-type cells from a G1 arrest in nocodazole (Fig. 6). As 
expected, cells overexpressing ScMad2
∆C but not those over-
expressing full-length ScMad2 in a wild-type background lost 
sister chromatid cohesion and rebudded and re-replicated their 
chromosomes, which is indicative of a checkpoint defect. Thus, 
ScMad2
∆C has a dominant-negative effect on the SAC analo-
gous to that observed in vertebrate cells (Chen et al., 1999; 
Figure 5.  The O–C interaction of Mad2 is conserved in evolution. (A) Human O-Mad2 binds the Mad1–C-Mad2 complex. 50 μl of human Mad1–Mad2 
complex (10 μM of divalent complex) was combined stoichiometrically with 20 μM of human AlexaFluor488-Mad2
∆C and analyzed by SEC on a 
  Superdex-200 PC 3.2/30 column. Fractions between 1.15 and 1.85 ml were analyzed by SDS-PAGE. Human Mad1–Mad2 and Mad2 were expressed 
and puriﬁ  ed as described previously (De Antoni et al., 2005a). (B) AlexaFluor488-Mad2
∆C from S. cerevisiae was incubated with human Mad1–Mad2 
and analyzed as in A. (C) AlexaFluor488-ScMad2
wt was incubated with ScCdc20
195–212. This yeast C-Mad2–Cdc20 complex did not bind human Mad1–
Mad2. (D) AlexaFluor488-HsMad2
∆C was incubated stoichiometrically with yeast Mad1–Mad2 and analyzed as in A. (E) AlexaFluor488-HsMad2
wt was 
incubated with a synthetic peptide encompassing the Mad2-binding segment of HsCdc20 (Cdc20
111–138). This human C-Mad2–Cdc20 complex did not 
bind yeast Mad1–Mad2. AU, arbitrary unit.MAD2 ACTIVATION IN THE SPINDLE CHECKPOINT • NEZI ET AL. 47
  Canman et al., 2002; De Antoni et al., 2005a), which is in agree-
ment with our hypothesis that this mutant interferes with the 
  interaction of Mad2
wt with Cdc20. Although we have been 
thus far unable to coimmunoprecipitate the complex between 
ScMad2
∆C and the Mad1–Mad2 complex, we show that 
ScMad2
∆C overexpressed from the GAL1 promoter in a mad2∆ 
strain was unable to bind Mad1 (Fig. S1 C).
Mad2
R126A and Mad2
Q127A bind Mad1 
normally but fail to bind Cdc20 in vivo
As shown in Fig. 2 and in Table S1, Mad2
wt and Mad2
RQEA bind 
Mad1 and Cdc20 effectively in vitro (the single mutants Mad2
RA 
and Mad2
QA bind equally well; unpublished data). However, the 
reintroduction of MAD2
wt at the endogenous LEU2 locus of a 
mad2∆ strain restored the SAC, whereas the expression of 
mad2
RA and mad2
QA failed to do so (Fig. 1). Because our model 
proposes that the interaction of the Mad2 conformers is essen-
tial to activate Mad2 for Cdc20 binding, Mad2 mutants that are 
unable to sustain this interaction should be unable to reach 
Cdc20 in living cells. We decided to assess the amounts of Mad1 
and Cdc20 that bound to Mad2
wt, Mad2
RA, and Mad2
QA ex-
pressed in a mad2∆ background. The association of Mad1 with 
Mad2 is not regulated during the cell cycle (Chen et al., 1999). 
To test the ability of Mad2 and its mutant variants to bind Mad1, 
we performed Mad1-myc18 immunoprecipitations (IPs) from 
cycling cells of MAD1-myc18 MAD2 and MAD1-myc18 mad2∆ 
strains carrying the MAD2
wt, mad2
RA, and mad2
QA alleles inte-
grated at the LEU2 locus. Consistent with their ability to bind 
Mad1 in vitro, Mad2
RA and Mad2
QA were found to associate 
with Mad1 in vivo as effi  ciently as Mad2
wt (Fig. 7 A). 
Unlike the levels of Mad1 and Mad2, which are essen-
tially constant during the cell cycle, Cdc20 is a cell cycle–
  regulated protein whose destruction is required for mitotic exit 
(Peters, 2002). Thus, we investigated the levels of Mad2 and 
its mutant variants associated with Cdc20 during mitosis, when 
CDC20 expression is maximal (Peters, 2002). For this, myc18-
CDC20 MAD2 cells and myc18-CDC20 mad2∆ cells carrying 
the MAD2
wt, mad2
RA, and mad2
QA alleles integrated at the LEU2 
locus were arrested in G1 with α factor and were released into 
the cell cycle in the presence of nocodazole, which activates the 
SAC, promoting the formation of the Mad2–Cdc20 complex. 
All three strains reentered the cell cycle normally and completed 
DNA replication synchronously roughly 60 min after release 
Figure 6.  Mad2
𝖫C has a dominant-negative 
effect on the checkpoint. Strains with the in-
dicated genotypes were grown to log phase 
in YEPR medium, arrested in G1 by α factor, 
and released into YEPRG medium containing 
  nocodazole. 1% galactose was added to the 
cultures half an hour before the release to 
induce the GAL1 promoter. At the indicated 
times, cell samples were withdrawn for FACS 
analysis of DNA contents (A) and to score the 
percentage of budded and rebudded cells 
as well as the percentage of sister chromatid 
  separation (B).
Figure 7.  Mutations in the binding interface between O- and C-Mad2 
  impair Cdc20 binding. (A) Protein extracts were prepared from cycling 
cells of untagged wild-type (W303; lanes 1 and 6), MAD1-myc18 MAD2 
(ySP2218; lanes 2 and 7), and MAD1-myc18 mad2∆ strains carrying the 
MAD2
wt (ySP5314; lanes 3 and 8), mad2
RA (ySP5316; lanes 4 and 9), 
and mad2
QA (ySP5318; lanes 5 and 10) alleles integrated at the LEU2 
  locus. Total extracts and anti-myc IPs were analyzed by Western blotting 
(WB) to detect Mad1-myc18 and Mad2. (B) Cycling cultures of untagged 
wild-type (W303; lanes 1 and 6), myc18-CDC20 MAD2 (ySP1413; lanes 
2 and 7), and myc18-CDC20 mad2∆ strains carrying, respectively, the 
MAD2
wt (ySP5311; lanes 3 and 8), mad2
RA (ySP5355; lanes 4 and 9), 
and mad2
QA (ySP5356; lanes 5 and 10) alleles integrated at the LEU2 
  locus were arrested in G1 by α factor and released in the presence of 
  nocodazole. After 80 min, cells were collected, and protein extracts were 
used for IPs with anti-myc antibodies. FACS analysis (not depicted) con-
ﬁ   rmed that cells were in G2/M. Total extracts and immunoprecipitates 
were analyzed by Western blotting to visualize myc18-Cdc20 and Mad2. 
(C) The same extracts as in B were used for IPs with anti-Mad2 polyclonal 
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from the arrest. To assess the amounts of Mad2 bound to Cdc20, 
IPs were performed from extracts of cells harvested 80 min after 
release from the G1 arrest. To confi  rm that these cells were in 
mitosis regardless of their genotype, we monitored the levels of 
the mitotic cyclin Clb2. These were found to be identical (Fig. 
7 B), showing that both checkpoint-profi  cient (MAD2
wt) and 
checkpoint-defi  cient (mad2
RA or mad2
QA) cells had been har-
vested while in mitosis. Although Mad2
wt expressed in mad2∆ 
cells bound normally to myc-Cdc20, the binding of Mad2
RA 
and Mad2
QA to myc-Cdc20 was severely impaired (Fig. 7 B). In 
the converse experiment, we found greatly diminished levels of 
myc-Cdc20 in Mad2 IPs (Fig. 7 C). Overall, these results indi-
cate that the differences in the amount of Mad2–Cdc20 complex 
in cells expressing Mad2
wt, Mad2
RA, or Mad2
QA must be the 
result of the inability of the mutant proteins to support the in-
teraction of O- with C-Mad2. We conclude that this interaction 
represents a critical step in the activation of Mad2 in the SAC.
Discussion
In this study, we show that two critical features of Mad2—the 
ability to adopt open and closed conformations and dimeriza-
tion of the open and closed conformers—are both likely to be 
conserved in all eukaryotes. Both features appear to be required 
for Mad2 to bind Cdc20 and to sustain the checkpoint. We pro-
vide convincing evidence that recombinant ScMad2 folds as an 
O-Mad2 monomer that changes its conformation to C-Mad2 
upon binding Mad1 or Cdc20. Recombinant HsMad2 forms 
  oligomers in the absence of Mad1 or Cdc20 (Fang et al., 1998). 
We have reanalyzed the mechanism of oligomerization of 
  HsMad2 and found that the Mad2 oligomers are O–C dimers 
created by the partial, spontaneous conversion of O-Mad2 into 
an “empty” C-Mad2 (i.e., devoid of Mad1 or Cdc20), which, in 
turn, binds the remaining O-Mad2 (De Antoni et al., 2005b). 
Thus, HsMad2 oligomerization in vitro (Fang et al., 1998) ap-
pears to be based on the same O–C Mad2 interaction supporting 
the checkpoint but in the absence of Mad2 ligands. We suspect 
that empty C-Mad2 is unlikely to be the active Mad2 species, as 
proposed recently (Luo et al., 2004). Our skepticism in regard-
ing empty C-Mad2 as the direct binder of Cdc20 is based on the 
fact that the specifi  c closed conformation of the Mad2 C-terminal 
tail would prevent the loading of Cdc20 onto empty C-Mad2 
(Musacchio and Hardwick, 2002; Sironi et al., 2002). It seems 
sensible to suggest that if empty C-Mad2 ever formed in living 
cells, it would then need to unfold its C-terminal tail to be able 
to bind Cdc20. The reason why recombinant HsMad2 rear-
ranges spontaneously to create empty C-Mad2, whereas recom-
binant ScMad2 does not appear to do so, is currently unclear.
Our work shows identical mechanisms of O–C oligomer-
ization for ScMad2 and HsMad2. As for HsMad2 (De Antoni 
et al., 2005b), the O- and C-Mad2 conformers of ScMad2 bind 
each other, whereas neither of them forms oligomers on their 
own. These observations are inconsistent with the proposition 
that C-Mad2 forms C–C dimers (Luo et al., 2004). However, 
our results are completely consistent with an earlier study from 
the same authors showing that C-Mad2 created using the Mad2-
binding site of Cdc20 is a monomer (Luo et al., 2002). It is in-
teresting to observe that because O–O and C–C dimers are not 
observed, there is a logical requirement for the O- and C-Mad2 
surfaces involved in the O–C interaction to be different. The 
identifi  cation of residues whose mutation into alanine prevents 
binding of the mutant C-Mad2 conformer to wild-type O-Mad2 
while leaving unaltered the ability of the mutant O conformer to 
bind wild-type C-Mad2 (Mapelli et al., 2006) confi  rms the idea 
that the specifi  city of the O–C dimerization is caused by ele-
ments of structural asymmetry.
Conversely, Arg126 and Gln127 belong to a class of 
“symmetric” residues whose mutation affects binding to the 
opposite conformer both in the O and C state (suggesting, but 
not implying, that some level of symmetry at the O–C inter-
face might also be present). This gives us an opportunity to ex-
plain our choice for using single or double point mutants of 
Arg126 and Gln127 (Mad2
RA or Mad2
QA vs. Mad2
RQEA) in dif-
ferent   experiments. Although single point mutants Mad2
RA and 
Mad2
QA display signifi  cant residual binding to a wild-type ver-
sion of the opposite conformer, the double mutant Mad2
RQEA is 
signifi  cantly more penetrant and devoid of any signifi  cant resid-
ual binding activity toward the opposite conformer of Mad2
wt 
(De Antoni et al., 2005a,b). Thus, we will use Mad2
RQEA if we 
want to test the interaction of a mutant Mad2 conformer to the 
opposite conformation of Mad2
wt. On the other hand, the single 
point mutants Mad2
RA or Mad2
QA will be suffi  cient to disrupt 
binding if both binding interfaces are mutated. Accordingly, 
mad2
RA and mad2
QA alleles that are reintroduced in a mad2∆ 
strain are unable to reconstitute the SAC. In vitro, the level of 
disruption of the O-Mad2–C-Mad2 interaction observed in this 
case is roughly similar to that observed when testing the double 
point mutant RQEA against a wild-type surface (De Antoni 
et al., 2005b).
Fig. 8 provides a schematic account of the Mad2 template 
model. A stable Mad1–C-Mad2 complex recruits O-Mad2 from 
the cytosol via the O–C-Mad2 interaction, favoring its transfor-
mation into C-Mad2 bound to Cdc20. Strong in vivo evidence 
for the Mad2 template model comes from FRAP experiments 
revealing the presence of two distinct and quantitatively equiv-
alent kinetochore pools of Mad2 with fast and slow turnover 
(Shah et al., 2004; Vink et al., 2006). In the molecular descrip-
tion of the Mad2 template model, the stable and mobile pools of 
Mad2 coincide with Mad1-bound C-Mad2 and C-Mad2–bound 
O-Mad2, respectively. Formal proof that these two pools account 
for the FRAP rates observed in vivo needs to be provided.
Because our data show that the Mad2–Cdc20 interaction 
in yeast requires O-Mad2–C-Mad2 binding, it is puzzling that 
Mad2 and Cdc20 bind spontaneously in vitro. A possible expla-
nation for this apparent discrepancy is that the noncatalyzed 
rate of formation of the Mad2–Cdc20 complex is too slow to al-
low the accumulation of Mad2–Cdc20 that is required to sustain 
the SAC (Fig. 8). We speculate that the mechanistic signifi  cance 
of the interaction of O-Mad2 with Mad1-bound C-Mad2 is that 
the latter acts as a catalyst for the otherwise slow transformation 
of O-Mad2 into Cdc20-bound C-Mad2. A large energy barrier 
(and correspondingly slow kinetics) is expected for the confor-
mational change required to turn O-Mad2 into C-Mad2, which 
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2004; Sironi et al., 2002). C-Mad2 may trigger the reorganiza-
tion of the C-terminal tail of O-Mad2, creating a structural 
  intermediate for its conversion into C-Mad2. The enrichment 
of Cdc20 at kinetochores would also favor its capture in a 
C-Mad2–Cdc20 complex. This reaction may also be negatively 
regulated. A negative regulator of the SAC such as p31
comet 
(Habu et al., 2002; Xia et al., 2004), which binds exclusively 
to C-Mad2 and, therefore, is likely to act as a competitor of 
O-Mad2, might be expected to decrease the levels of C-Mad2 
available to bind O-Mad2. However, a functional homologue of 
this protein has not yet been identifi  ed in S. cerevisiae, so the 
generality of this hypothesis remains unclear.
The fact that a mutational impairment of the O-Mad2–
C-Mad2 interaction abrogates the SAC acts in support of the 
Mad2 template model. Our experiments are unable to distin-
guish whether the C-Mad2–O-Mad2 interaction specifi  cally re-
quires Mad1-bound C-Mad2. More specifi  cally, it is possible 
that this interaction also involves Cdc20-bound C-Mad2 in a 
positive feedback loop (Fig. 8 F) as we have suggested previ-
ously (De Antoni et al., 2005a,b). Thus, it will now be essential 
to dissect the specifi  c functions of the C-Mad2 pools bound to 
Mad1 and Cdc20.
Materials and methods
Yeast strains, media, and reagents
Standard genetic techniques were used to manipulate yeast strains (Sher-
man, 2002). All yeast strains were derivatives of W303 (ade2-1, trp1-1, 
leu2-3, 112, his3-11, 15, ura3, and ssd1) and are listed in Table I. Cells 
were grown in YEP medium (1% yeast extract, 2% bactopeptone, and 
50 mg/l adenine) supplemented with 2% glucose (YEPD), 2% rafﬁ  nose 
(YEPR), or 2% rafﬁ  nose and 1% galactose (YEPRG). α Factor was used at 
2 μg/ml, and nocodazole was used at 15 μg/ml. All strains were nor-
mally grown at 25°C.
Plasmid construction and genetic manipulations
pGEX-ScMAD1
563–590 and pGEX-ScCDC20
184–210 contain the coding 
  sequence of ScMad1
563–590 and Cdc20
184–210, respectively. pET43-
ScMAD2–6His-ScMAD1
529–750 contains the coding sequence of S. cerevisiae 
MAD2 separated from S. cerevisiae 6His-MAD1
529–750 by a ribosome-
binding site. We generated pET43-6His-ScMAD2, pET43-6His-
  Scmad2
R126E/Q127A, and pET43-6His-Scmad2
∆C by replacing the 
BamHI–EcoRI fragment of pET43-6His-Mad2 (De Antoni et al., 2005a) with 
coding sequences of ScMAD2 mutant alleles. The ScMAD2 HindIII–BglII 
fragment containing the whole coding region plus  400 bp of upstream 
and  280 bp of downstream sequence was cloned in HindIII–BamHI of 
YIplac128. The resulting pSP42 plasmid was integrated at the LEU2   locus 
by EcoRV   digestion. GAL1-MAD2 and GAL1-mad2∆C fusions as well as a 
mad2∆C allele under the control of  400 bp of MAD2 promoter were 
cloned in YIplac128 upstream of  280 bp of MAD2 terminator to generate 
pSP187, pSP385, and pSP384 plasmids, whose integration was directed 
to the LEU2 locus by EcoRV digestion. Single integrations were checked 
by   Southern analysis. Mutant alleles were generated using QuikChange 
(  Stratagene). MAD1 was tagged with the myc tag immediately before the 
stop codon by one-step gene tagging (Knop et al., 1999). The myc18-
CDC20 strain has been described previously (Shirayama et al., 1998).
Expression, puriﬁ  cation, and AlexaFluor labeling of proteins
ScMad2–6His-ScMad1
529–750 was generated in Escherichia coli BL21- 
c41(DE3). After metal afﬁ  nity chromatography on a 1-ml HiTrap Chelating 
HP column (GE Healthcare), the protein was puriﬁ  ed by ion exchange on 
a Resource Q column (GE Healthcare) and dialyzed in buffer L (20 mM 
Hepes, pH 7.5, 300 mM NaCl, 10% glycerol, and 1 mM EDTA). Mad2 
proteins were expressed in E. coli BL21(DE3) and puriﬁ  ed essentially as 
described previously for the human complex (Sironi et al., 2001). Proteins 
were labeled with AlexaFluor488 succimidyl ester reactive dye (Invitrogen) 
as described previously (Howell et al., 2000), with a ﬁ  nal dye/protein 
  ratio of  0.5.
Analytical SEC
Analytical SEC was performed on a SMART device (GE Healthcare) using 
Superdex-75 or -200 PC 3.2/30 columns equilibrated in buffer L. 10 μM 
Figure 8.  Implications of the Mad2 template model. (A) There are two pools of Mad2: a cytosolic O-Mad2 pool and a C-Mad2 pool bound to Mad1. 
The latter is a template required to create C-Mad2 bound to Cdc20, the “copy.” In the absence of Mad1–Mad2, the Mad2–Cdc20 complex does not form 
  efﬁ  ciently. We speculate that the binding reaction, which implies a big conformational change for Mad2, is slow. (B) O-Mad2 is recruited from the cytosolic 
to Mad1–Mad2 at the kinetochore. Within the core complex, C-Mad2 is responsible for the interaction with O-Mad2. (C) Recruitment to the Mad1–Mad2 
complex is impaired if Mad2 contains mutations such as RA and QA that affect its ability to bind O-Mad2. Under these conditions, the checkpoint cannot 
be activated. (D) The O-Mad2 molecule bound to C-Mad2 binds Cdc20 to create a new C-Mad2 conformer. The green circle enclosing O-Mad2 signiﬁ  es 
that this monomer, not the C-Mad2 monomer bound to Mad1, is transferred to Cdc20. The representation of this monomer as O-Mad2 is possibly a 
  simpliﬁ  cation. Because we presume that prior binding of O-Mad2 to C-Mad2 accelerates binding to Cdc20 relative to cytosolic O-Mad2, this monomer 
might be characterized by a partially unfolded conformation of the C-terminal tail of Mad2, representing a transition state from the open to the closed 
  conformation. (E) The C-Mad2–Cdc20 complex is a copy of the C-Mad2–Mad1 complex (the template). The decisive difference between these complexes 
is likely that Mad1–Mad2 is very stable, whereas Cdc20–Mad2 exists transiently and its concentrations can be reversed. (F) The Mad2 template hypothesis 
postulates that C-Mad2–Cdc20 acts in the cytosol like C-Mad2–Mad1 at the kinetochore. The reaction is similar to that shown in B. In comparison with C, 
it is easy to see that the RA and QA Mad2 mutants will also be unable to promote this step. The hypothetical reaction shown in this panel has the character 
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of divalent ScMad2–6His-ScMad1
529–750 complex was incubated for 1 h at 
25°C with 20 μM AlexaFluor-ScMad2 or AlexaFluor-ScMad2 mutants. The 
reactions were separated by SEC. Elution was performed at 40 ml/min. 
Custom-built synthetic peptides were purchased from Eurogentec.
Protein extracts, IPs, and Western blotting analysis
For IPs, cells were lysed with glass beads in 50 mM Hepes, pH 7.6, 
75 mM KCl, 1 mM MgCl2, 1 mM EGTA, 1 mM AEBSF, 0.5 mM DTT, 
120 mM β-glycerophosphate, and 0.1% Triton X-100 supplemented with a 
cocktail of protease inhibitors (Complete; Boehringer). 1–2 mg of cleared 
extracts was incubated for 2 h with antibody directly cross-linked to protein 
A–Sepharose, except in the case of the anti-Mad2 IPs. The slurry was 
washed three times with lysis buffer. Protein extracts were run on 15% SDS-
PAGE gels. For Western blot analysis, proteins were transferred to Protran 
membranes. myc18-Cdc20 and Mad1-myc18 were detected with mono-
clonal antibody 9E10. Anti-Clb2 polyclonal antibodies were a gift from 
W. Zachariae (Max Planck Institute of Molecular Cell Biology and   Genetics, 
Dresden, Germany). Anti-ScMad2 polyclonal antibodies used for Fig. 7 A 
and SF1C were provided by K. Hardwick (Wellcome Trust Centre for Cell 
Biology, University of Edinburgh, Edinburgh, UK; Hardwick et al., 2000). 
Anti-ScMad2 polyclonal antibodies used for Fig. 7 (B and C) were pro-
duced locally. Secondary antibodies were purchased from GE Healthcare 
and Bio-Rad Laboratories.
GST-binding assay
GST-ScMad1
563–590 and GST-ScCdc20
184–210 were expressed in E. coli 
BL21-c41(DE3). After lysis by sonication in buffer A (10 mM Hepes, 
pH 7.5, 100 mM NaCl, 1 mM DTT, and 0.5 mM EDTA), 1% Triton X-100 
was added. The GST proteins were puriﬁ   ed with GSH agarose (GE 
  Healthcare).  8 μg GST, GST-ScMad1
563–590, or GST-ScCdc20
184–210 on 
beads were incubated for 1 h at RT with 40 μg ScMad2, ScMad2
∆C, or 
  ScMad2
RQEA in 0.3 ml of buffer A (ﬁ  nal concentrations of GST fusion pro-
tein and Mad2 were  1 and  5 μM, respectively). Beads were washed 
twice with 0.4 ml of buffer A supplemented with 1% Triton X-100, and 
bound proteins were separated by SDS-PAGE.
Flow cytometry and analysis of sister chromatid separation
Flow cytometric DNA quantitation was determined on a FACScan (Becton 
Dickinson) as described previously (Epstein and Cross, 1992). Sister chro-
matid separation was followed on ethanol-ﬁ   xed cells by visualizing 
  tetracycline-repressor GFP fusion proteins bound to tandem repeats of tet 
operators integrated at  35 kb away from the centromere of chromosome V 
(Michaelis et al., 1997).
Online supplemental material
Fig. S1 shows the characterization of Mad2
∆C in S. cerevisiae. Table 
S1 provides data on isothermal titration calorimetry. Online supple-
mental material is available at http://www.jcb.org/cgi/content/full/
jcb.200602109/DC1.
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